Effectiveness of Probiotics in Relieving Allergic Rhinitis in Children

Exclusion Criteria

• •1. Drugs that affect the intestinal flora (including antibacterial drugs, probiotics, intestinal mucosal protective agents, traditional Chinese patent medicines and simple preparations, etc.) are continuously used for more than one week within one month before screening;
• •2. Merge with tuberculosis patients;
• •3. Combined with allergic asthma;
• •4. Patients with nasal polyps or severe nasal septum deviation;
• •5. Patients with serious systemic diseases or malignant tumors;
• •6. Individuals with congenital genetic disorders or congenital immunodeficiency diseases;
• •7. Regular use of probiotics or prebiotics within the first 6 months of the screening period;
• •8. Individuals with severe gastrointestinal diseases (including severe diarrhea, inflammatory bowel disease, etc.);
• •9. Those with metabolic syndrome (including obesity, abnormal lipid metabolism, hypertension, diabetes, etc.);
• •10. Patients with combined sinusitis, otitis media, or respiratory infections;
• •11. Stop taking the test sample or add other drugs midway, unable to determine efficacy or incomplete data;
• •12. Short term use of substances with similar functions to the test subject affects the judgment of the results;
• •13. The subject is unable to participate in the trial due to personal reasons;
• •14. Participants deemed unsuitable by other researchers to participate. Those who meet any of the above conditions shall not be selected.